Definitive Contract 75N91021C00012
Award Date
7/9/21
Potential Completion Date
11/30/25
Potential Value
$681K
Federal Agency
National Cancer Institute
Awardee
Westat, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Westat, Inc., a for-profit professional services firm based in Rockville, Maryland. The contract is for a "COORDINATING CENTER FOR CONTINUATION OF FOLLOW-UP OF DES-EXPOSED COHORTS" and has a period of performance from September 30, 2016 to April 29, 2021 with a ceiling value of $872,088.03. The contract does not have a set-aside...
This is a definitive contract awarded by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services, to Trustees of Dartmouth College's Office of Sponsored Projects division. The contract, valued at $1,246,730.00, is for the continuation of follow-up studies on cohorts exposed to diethylstilbestrol (DES), a synthetic estrogen drug that was commonly prescribed to pregnant women in the past. The contract does not have a set-aside designation. As the...
This federal contract award was issued by the National Cancer Institute (NCI), part of the Department of Health and Human Services, to the University of Massachusetts Medical School (UMMS) for the "CONTINUATION OF FOLLOW-UP OF DES-EXPOSED COHORTS" project. The $1,485,274.31 contract is a definitive cost-no-fee contract and does not have a set-aside designation. Under this award, UMMS is the prime contractor managing the overall study, which involves long-term follow-up of cohorts...
<p>This is a definitive contract awarded by the National Cancer Institute, a civilian agency, to the University of Chicago for the continuation of follow-up of a cohort exposed to Diethylstilbestrol (DES). The contract has a ceiling value of $1,314,591.00 and does not have a set-aside designation. The contract type is cost no fee, and the ultimate completion date is September 29, 2015.</p>
This is a definitive federal contract awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to the Trustees of Boston University, doing business as Boston University Medical Campus. The contract, valued at $1,220,033.73, is for the continuation of follow-up of cohorts exposed to diethylstilbestrol (DES) in utero. The work includes mailing questionnaires, conducting interviews, validating outcomes, data analysis, and developing future questionnaires....
This is a definitive contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract, titled "INTERDISCIPLINARY STUDIES OF OCCUPATIONAL AND ENVIRONMENTAL CANCER," has a ceiling value of $130,431,971.00 and a completion date of December 31, 2007. It is a cost-plus-fixed-fee contract, meaning the government reimburses the contractor for allowable costs incurred...
This is a definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract, valued at $21,903,489.00, is for support services related to biostatistical and etiological studies. The contract does not have a set-aside designation. Westat, Inc. has extensive experience working with various federal agencies, providing services such as survey research, data...
This is a $21,248,975.00 cost-plus-fixed-fee delivery order contract awarded to Westat, Inc., a professional services firm in Rockville, Maryland, by the National Cancer Institute (NCI). The contract provides clinical, genetic, and epidemiological support services under the Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The contract does not have a small business set-aside designation....
This federal contract award supports the Agriculture Health Study (AHS) program under the National Cancer Institute (NCI). The contractor, Westat, Inc., will serve as the coordinating center for all study activities in the sixth phase of the AHS contract. Westat will work closely with the AHS Executive Committee and Contracting Officer Representative on the tasks outlined in the contract. The contract is a cost-plus-fixed-fee arrangement with a ceiling value of $4,732,248 and an ultimate...
This is a federal contract award to Westat, Inc., a professional services firm, by the National Cancer Institute (NCI), a civilian agency under the Department of Health and Human Services. The $10,071,871.00 cost-plus-fixed-fee contract is for biomedical (applied/exploratory) services and has a completion date of September 29, 2005. The contract is not set aside. Westat has extensive experience providing research, technical assistance, and program support services to various federal agencies,...